Analysis of gene expression profiles of lung adenocarcinomas using amplified mRNA
C. Seifart, U. Clostermann, O. Hartmann, T. Goldmann, E. Vollmer, D. Branscheid, C. Vogelmeier (Marburg, Borstel, Germany)
Source: Annual Congress 2003 - Molecular biology of chronic lung disease and lung cancer
Disease area: Thoracic oncology
Abstract Although risk factors for carcinomas of the lung are well recognized, very little is known about the molecular mechanisms responsible for this malignancy. cDNA microarrays are capable of profiling gene expression patterns of thousands of genes and/or gene clusters. However, this system is limited by the large amount of RNA required per hybridization. Therefore, we analyzed gene expression profiles of 20 sets of surgical specimen of adenocarcinomas of the lung and corresponding non-neoplastic lung tissue from the same individual using amplified mRNA to constitute molecular genetic portraits of those tumors. Gene expression profiles were examined using a 5000-element cDNA microarray. Total RNA was extracted from frozen normal or cancer tissue. mRNA was amplified from total RNA and used for hybridisation. A panel of 20 primary adenocarcinomas were analysed with a reference RNA derived each from their corresponding non-neoplastic lung tissues. Initially, linear amplification of mRNA by used amplification procedure were controlled using total RNA and mRNA of two cell lines. The data revealed 37 genes with high significantly different expression between cancer and non-neoplastic lung tissue. Using a threshold of 4-fold ( fold change=fc ≥ 4.0) over- or underexpression 23 genes remained. These include topoisomerase II alpha, genes involved in ubiquitination, LIM-domain proteins and other several transcription genes, showing diversity of gene expression in adenocarcinoma. Funded by BMBF 1GC6901/5
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Seifart, U. Clostermann, O. Hartmann, T. Goldmann, E. Vollmer, D. Branscheid, C. Vogelmeier (Marburg, Borstel, Germany). Analysis of gene expression profiles of lung adenocarcinomas using amplified mRNA. Eur Respir J 2003; 22: Suppl. 45, 1506
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Comparative gene expression analysis in lung cancer Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Gene expression patterns in lung emphysema. A gene microarray analysis Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002
Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007
Gene expression profiling of lung adenocarcinoma by microarray analysis Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005
Differential expression analysis of lncRNA in different types of lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021
Analysis of the cytokine gene expression profile of TNFα treated BEAS-2B cells by cDNA array Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
Microarray gene expression profiles in lung tissue of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007
Distribution and mRNA expression of tenascin-C in developing human lung Source: Eur Respir J 2001; 18: Suppl. 33, 244s Year: 2001
Glutathione S-transferase copy number variation alters lung gene expression Source: Eur Respir J 2011; 37: 15-28 Year: 2011
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue Source: Eur Respir J, 56 (3) 2001123; 10.1183/13993003.01123-2020 Year: 2020
In silico gene expression analysis of small cell lung cancer Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Prognosis related gene expression profile in early-stage squamous cell carcinoma of the lung (SqCLC) by real-time quantitative PCR (RT-QPCR) Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007
A nasal gene expression profile differentiates individuals with and without COPD and overlaps bronchial gene expression Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017
The differential expression profiles from a set of 24 genes between 8.500 are involved in adenocarcinoma detection Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013
MicroRNA profiling in bronchial biopsies identifies altered expression in asthma and high levels of allergen-modulated epithelial microRNAs Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021
MDM2 gene amplification and mdm2 protein expression in NSCLC cells Source: Eur Respir J 2005; 26: Suppl. 49, 91s Year: 2005
Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Differential gene expression in primary bronchial epithelial cells from COPD patients and control subjects. Evaluation by means of a cDNA array for cytokines and cytokine related genes Source: Eur Respir J 2002; 20: Suppl. 38, 483s Year: 2002
Changes in gene expression associated with COPD revealed by low density microarray analysis Source: Eur Respir J 2006; 28: Suppl. 50, 584s Year: 2006